Published in Front Mol Neurosci on March 23, 2010
Presynaptic glycine receptors as a potential therapeutic target for hyperekplexia disease. Nat Neurosci (2014) 1.49
Inhibitory glycine receptors: an update. J Biol Chem (2012) 1.02
The impact of human hyperekplexia mutations on glycine receptor structure and function. Mol Brain (2014) 1.02
Allosteric and hyperekplexic mutant phenotypes investigated on an α1 glycine receptor transmembrane structure. Proc Natl Acad Sci U S A (2015) 0.94
Clinical and Immunologic Investigations in Patients With Stiff-Person Spectrum Disorder. JAMA Neurol (2016) 0.93
New hyperekplexia mutations provide insight into glycine receptor assembly, trafficking, and activation mechanisms. J Biol Chem (2013) 0.93
Mutations in the GlyT2 gene (SLC6A5) are a second major cause of startle disease. J Biol Chem (2012) 0.93
Altered sedative effects of ethanol in mice with α1 glycine receptor subunits that are insensitive to Gβγ modulation. Neuropsychopharmacology (2014) 0.82
4-Chloropropofol enhances chloride currents in human hyperekplexic and artificial mutated glycine receptors. BMC Neurol (2012) 0.80
Drug elucidation: invertebrate genetics sheds new light on the molecular targets of CNS drugs. Front Pharmacol (2014) 0.78
4-bromopropofol decreases action potential generation in spinal neurons by inducing a glycine receptor-mediated tonic conductance. Br J Pharmacol (2014) 0.78
Murine startle mutant Nmf11 affects the structural stability of the glycine receptor and increases deactivation. J Physiol (2016) 0.77
Glycinergic transmission: physiological, developmental and pathological implications. Front Mol Neurosci (2010) 0.76
The astrocytic transporter SLC7A10 (Asc-1) mediates glycinergic inhibition of spinal cord motor neurons. Sci Rep (2016) 0.75
A confusing coincidence: neonatal hypoglycemic seizures and hyperekplexia. Case Rep Med (2014) 0.75
Defects of the Glycinergic Synapse in Zebrafish. Front Mol Neurosci (2016) 0.75
Basic local alignment search tool. J Mol Biol (1990) 659.07
T-Coffee: A novel method for fast and accurate multiple sequence alignment. J Mol Biol (2000) 57.88
The complete genome of an individual by massively parallel DNA sequencing. Nature (2008) 52.81
Database resources of the National Center for Biotechnology Information. Nucleic Acids Res (2007) 22.53
Crystal structure of a bacterial homologue of Na+/Cl--dependent neurotransmitter transporters. Nature (2005) 12.56
The development and impact of 454 sequencing. Nat Biotechnol (2008) 4.60
Tools for comparative protein structure modeling and analysis. Nucleic Acids Res (2003) 3.68
Genes controlling and mediating locomotion behavior of the zebrafish embryo and larva. Development (1996) 3.15
The vesicular GABA transporter, VGAT, localizes to synaptic vesicles in sets of glycinergic as well as GABAergic neurons. J Neurosci (1998) 2.76
The beta subunit determines the ligand binding properties of synaptic glycine receptors. Neuron (2005) 2.42
Mutations in the alpha 1 subunit of the inhibitory glycine receptor cause the dominant neurologic disorder, hyperekplexia. Nat Genet (1993) 2.35
Paroxysmal extreme pain disorder (previously familial rectal pain syndrome). Neurology (2007) 2.22
Progressive encephalomyelitis, rigidity, and myoclonus: a novel glycine receptor antibody. Neurology (2008) 2.13
Native glycine receptor subtypes and their physiological roles. Neuropharmacology (2008) 2.06
Deletion of the mouse glycine transporter 2 results in a hyperekplexia phenotype and postnatal lethality. Neuron (2003) 1.97
Startle syndromes. Lancet Neurol (2006) 1.93
Inactivation of the glycine transporter 1 gene discloses vital role of glial glycine uptake in glycinergic inhibition. Neuron (2003) 1.84
The GDP-GTP exchange factor collybistin: an essential determinant of neuronal gephyrin clustering. J Neurosci (2004) 1.75
Glycine transporters: essential regulators of neurotransmission. Trends Biochem Sci (2005) 1.68
Glycine receptor beta-subunit gene mutation in spastic mouse associated with LINE-1 element insertion. Nat Genet (1994) 1.64
The genetics of hyperekplexia: more than startle! Trends Genet (2008) 1.49
Mutations in the gene encoding GlyT2 (SLC6A5) define a presynaptic component of human startle disease. Nat Genet (2006) 1.49
Demonstration of functional coupling between gamma -aminobutyric acid (GABA) synthesis and vesicular GABA transport into synaptic vesicles. Proc Natl Acad Sci U S A (2003) 1.43
A missense mutation in the gene encoding the alpha 1 subunit of the inhibitory glycine receptor in the spasmodic mouse. Nat Genet (1994) 1.41
Disease, disorder, or deception? Latah as habit in a Malay extended family. J Nerv Ment Dis (1994) 1.40
The spastic mouse: aberrant splicing of glycine receptor beta subunit mRNA caused by intronic insertion of L1 element. Neuron (1994) 1.38
A balanced chromosomal translocation disrupting ARHGEF9 is associated with epilepsy, anxiety, aggression, and mental retardation. Hum Mutat (2009) 1.32
Startle disease or hyperekplexia: further delineation of the syndrome. Brain (1980) 1.32
Zebrafish bandoneon mutants display behavioral defects due to a mutation in the glycine receptor beta-subunit. Proc Natl Acad Sci U S A (2005) 1.28
Mutational analysis of familial and sporadic hyperekplexia. Ann Neurol (1995) 1.28
Gene knockout of glycine transporter 1: characterization of the behavioral phenotype. Proc Natl Acad Sci U S A (2004) 1.27
Crisponi syndrome is caused by mutations in the CRLF1 gene and is allelic to cold-induced sweating syndrome type 1. Am J Hum Genet (2007) 1.27
Hyperekplexia in neonates. Postgrad Med J (2001) 1.26
Evidence for recessive as well as dominant forms of startle disease (hyperekplexia) caused by mutations in the alpha 1 subunit of the inhibitory glycine receptor. Hum Mol Genet (1994) 1.24
Autoimmunity to gephyrin in Stiff-Man syndrome. Neuron (2000) 1.21
A family with emotionally precipitated drop seizures. Acta Psychiatr Neurol Scand (1958) 1.20
Biskit--a software platform for structural bioinformatics. Bioinformatics (2007) 1.19
Isoform heterogeneity of the human gephyrin gene (GPHN), binding domains to the glycine receptor, and mutation analysis in hyperekplexia. J Biol Chem (2003) 1.17
A frameshift mutation in the mouse alpha 1 glycine receptor gene (Glra1) results in progressive neurological symptoms and juvenile death. Hum Mol Genet (1994) 1.17
Hyperekplexia associated with compound heterozygote mutations in the beta-subunit of the human inhibitory glycine receptor (GLRB). Hum Mol Genet (2002) 1.16
ARHGEF9 disruption in a female patient is associated with X linked mental retardation and sensory hyperarousal. J Med Genet (2007) 1.16
High-throughput, high-accuracy array-based resequencing. Proc Natl Acad Sci U S A (2009) 1.14
RNA editing produces glycine receptor alpha3(P185L), resulting in high agonist potency. Nat Neurosci (2005) 1.12
Determination of the mutation spectrum of the EXT1/EXT2 genes in British Caucasian patients with multiple osteochondromas, and exclusion of six candidate genes in EXT negative cases. Hum Mutat (2006) 1.07
A mutation in the gene for the neurotransmitter receptor-clustering protein gephyrin causes a novel form of molybdenum cofactor deficiency. Am J Hum Genet (2000) 1.07
Mutation scanning the GJB1 gene with high-resolution melting analysis: implications for mutation scanning of genes for Charcot-Marie-Tooth disease. Clin Chem (2007) 1.07
Mutations within the human GLYT2 (SLC6A5) gene associated with hyperekplexia. Biochem Biophys Res Commun (2006) 1.06
Startle and its disorders. Neurophysiol Clin (2007) 1.06
Vesicular inhibitory amino acid transporter is a Cl-/gamma-aminobutyrate Co-transporter. J Biol Chem (2009) 1.03
Splice-specific roles of glycine receptor alpha3 in the hippocampus. Eur J Neurosci (2009) 1.02
Startle disease: an avoidable cause of sudden infant death. Lancet (1989) 1.00
Isoform-selective deficit of glycine receptors in the mouse mutant spastic. Neuron (1992) 0.98
Autosomal recessive disorder with muscle contractions resembling neonatal tetanus, characteristic face, camptodactyly, hyperthermia, and sudden death: a new syndrome? Am J Med Genet (1996) 0.98
Compound heterozygosity and nonsense mutations in the alpha(1)-subunit of the inhibitory glycine receptor in hyperekplexia. Hum Genet (2001) 0.97
The orphan transporter Rxt1/NTT4 (SLC6A17) functions as a synaptic vesicle amino acid transporter selective for proline, glycine, leucine, and alanine. Mol Pharmacol (2008) 0.96
Hyperekplexia associated with apnea and sudden infant death syndrome. Arch Pediatr Adolesc Med (1994) 0.93
The neuronal glycine transporter 2 interacts with the PDZ domain protein syntenin-1. Mol Cell Neurosci (2004) 0.91
Defective glycinergic synaptic transmission in zebrafish motility mutants. Front Mol Neurosci (2010) 0.88
The transporters GlyT2 and VIAAT cooperate to determine the vesicular glycinergic phenotype. J Neurosci (2007) 0.88
Hyperekplexia. Arch Neurol (1983) 0.88
A rat brain cDNA encoding the neurotransmitter transporter with an unusual structure. FEBS Lett (1993) 0.87
Characterization of the 5' region of the rat brain glycine transporter GLYT2 gene: identification of a novel isoform. Neurosci Lett (1998) 0.86
Hyperekplexia as cause of abnormal intrauterine movements. Lancet (1995) 0.86
The C-terminal PDZ-ligand motif of the neuronal glycine transporter GlyT2 is required for efficient synaptic localization. Mol Cell Neurosci (2007) 0.85
Cellular localization and subcellular distribution of Unc-33-like protein 6, a brain-specific protein of the collapsin response mediator protein family that interacts with the neuronal glycine transporter 2. J Neurochem (2005) 0.85
A critical role for glycine transporters in hyperexcitability disorders. Front Mol Neurosci (2008) 0.84
A familial convulsive disorder with an unusual onset during intrauterine life: a case report. J Pediatr (1960) 0.84
Stiff person syndrome. Front Neurol Neurosci (2009) 0.83
In vivo somatic delivery of plasmid DNA and retrograde transport to obtain cell-specific gene expression in the central nervous system. J Neurochem (2004) 0.79
Gene structure and alternative splicing of the mouse glycine transporter type-2. Biochem Biophys Res Commun (2004) 0.78
Bilateral inguinal hernia repair in a child with hyperekplexia. Paediatr Anaesth (2007) 0.77
Clinical and inheritance profiles of hyperekplexia in Jordan. J Child Neurol (2007) 0.76
Familial hyperekplexia and refractory status epilepticus: a new autosomal recessive syndrome. J Child Neurol (2004) 0.76
Hereditary early-onset Parkinson's disease caused by mutations in PINK1. Science (2004) 15.91
Kinase activity is required for the toxic effects of mutant LRRK2/dardarin. Neurobiol Dis (2006) 5.96
The mitochondrial protease HtrA2 is regulated by Parkinson's disease-associated kinase PINK1. Nat Cell Biol (2007) 4.60
GlyR alpha3: an essential target for spinal PGE2-mediated inflammatory pain sensitization. Science (2004) 3.38
Mutations in alpha-tubulin cause abnormal neuronal migration in mice and lissencephaly in humans. Cell (2007) 3.06
Potent and selective inhibition of human cytomegalovirus replication by 1263W94, a benzimidazole L-riboside with a unique mode of action. Antimicrob Agents Chemother (2002) 2.98
Highly effective SNP-based association mapping and management of recessive defects in livestock. Nat Genet (2008) 2.68
Neuroligin 2 drives postsynaptic assembly at perisomatic inhibitory synapses through gephyrin and collybistin. Neuron (2009) 2.44
PINK1 cleavage at position A103 by the mitochondrial protease PARL. Hum Mol Genet (2010) 2.30
Large spectrum of lissencephaly and pachygyria phenotypes resulting from de novo missense mutations in tubulin alpha 1A (TUBA1A). Hum Mutat (2007) 2.24
Glycine receptor autoimmune spectrum with stiff-man syndrome phenotype. JAMA Neurol (2013) 2.10
Gephyrin: where do we stand, where do we go? Trends Neurosci (2008) 2.10
Loss of imprinting of insulin growth factor II gene: a potential heritable biomarker for colon neoplasia predisposition. Gastroenterology (2004) 2.06
Altered cleavage and localization of PINK1 to aggresomes in the presence of proteasomal stress. J Neurochem (2006) 1.91
The GDP-GTP exchange factor collybistin: an essential determinant of neuronal gephyrin clustering. J Neurosci (2004) 1.75
Zinc-mediated inhibition of GABA(A) receptors: discrete binding sites underlie subtype specificity. Nat Neurosci (2003) 1.71
A revised nomenclature for the human and rodent alpha-tubulin gene family. Genomics (2007) 1.68
Claudin association with CD81 defines hepatitis C virus entry. J Biol Chem (2010) 1.67
A heterozygous effect for PINK1 mutations in Parkinson's disease? Ann Neurol (2006) 1.61
Mutations in GRIN2A cause idiopathic focal epilepsy with rolandic spikes. Nat Genet (2013) 1.59
Mutations in the guanine nucleotide exchange factor gene IQSEC2 cause nonsyndromic intellectual disability. Nat Genet (2010) 1.52
Mutations in the gene encoding GlyT2 (SLC6A5) define a presynaptic component of human startle disease. Nat Genet (2006) 1.49
The genetics of hyperekplexia: more than startle! Trends Genet (2008) 1.49
Impaired GABAergic transmission and altered hippocampal synaptic plasticity in collybistin-deficient mice. EMBO J (2007) 1.49
Weight change associated with antiepileptic drugs. J Neurol Neurosurg Psychiatry (2012) 1.43
The human cytomegalovirus UL44 protein is a substrate for the UL97 protein kinase. J Virol (2003) 1.42
Overlapping cortical malformations and mutations in TUBB2B and TUBA1A. Brain (2013) 1.40
Complex role of collybistin and gephyrin in GABAA receptor clustering. J Biol Chem (2010) 1.40
TUBA1A mutations cause wide spectrum lissencephaly (smooth brain) and suggest that multiple neuronal migration pathways converge on alpha tubulins. Hum Mol Genet (2010) 1.35
GRIN2B mutations in West syndrome and intellectual disability with focal epilepsy. Ann Neurol (2014) 1.34
Identification of large gene deletions and duplications in KCNQ1 and KCNH2 in patients with long QT syndrome. Heart Rhythm (2008) 1.33
Pathophysiological mechanisms of dominant and recessive GLRA1 mutations in hyperekplexia. J Neurosci (2010) 1.33
Insight into the mode of action of the LRRK2 Y1699C pathogenic mutant. J Neurochem (2011) 1.33
A balanced chromosomal translocation disrupting ARHGEF9 is associated with epilepsy, anxiety, aggression, and mental retardation. Hum Mutat (2009) 1.32
The residence time of GABA(A)Rs at inhibitory synapses is determined by direct binding of the receptor α1 subunit to gephyrin. J Neurosci (2011) 1.25
Glycinergic transmission in the Mammalian retina. Front Mol Neurosci (2009) 1.24
An ovine transgenic Huntington's disease model. Hum Mol Genet (2010) 1.24
Mutations in the LRRK2 Roc-COR tandem domain link Parkinson's disease to Wnt signalling pathways. Hum Mol Genet (2009) 1.22
Asymptomatic urethritis; the case for a considered view! Int J STD AIDS (2004) 1.22
Serotonin receptor 1A-modulated phosphorylation of glycine receptor α3 controls breathing in mice. J Clin Invest (2010) 1.21
Achieving optimal expression for single channel recording: a plasmid ratio approach to the expression of alpha 1 glycine receptors in HEK293 cells. J Neurosci Methods (2002) 1.19
Isoform heterogeneity of the human gephyrin gene (GPHN), binding domains to the glycine receptor, and mutation analysis in hyperekplexia. J Biol Chem (2003) 1.17
A short regulatory domain restricts glycerol transport through yeast Fps1p. J Biol Chem (2002) 1.17
The social value of a QALY: raising the bar or barring the raise? BMC Health Serv Res (2011) 1.13
RNA editing produces glycine receptor alpha3(P185L), resulting in high agonist potency. Nat Neurosci (2005) 1.12
Interactions of 1263W94 with other antiviral agents in inhibition of human cytomegalovirus replication. Antimicrob Agents Chemother (2003) 1.11
The first virally encoded cytochrome p450. J Virol (2009) 1.08
Genotype-phenotype correlations in hyperekplexia: apnoeas, learning difficulties and speech delay. Brain (2013) 1.06
Diversity of glycine receptors in the mouse retina: localization of the alpha4 subunit. J Comp Neurol (2007) 1.06
Subunit-specific modulation of glycine receptors by cannabinoids and N-arachidonyl-glycine. Biochem Pharmacol (2008) 1.05
The importance of Wnt signalling for neurodegeneration in Parkinson's disease. Biochem Soc Trans (2012) 1.04
A proposed structural basis for picrotoxinin and picrotin binding in the glycine receptor pore. J Neurochem (2007) 1.04
Localization of glycine receptors in the human forebrain, brainstem, and cervical spinal cord: an immunohistochemical review. Front Mol Neurosci (2009) 1.04
Collybistin splice variants differentially interact with gephyrin and Cdc42 to regulate gephyrin clustering at GABAergic synapses. J Cell Sci (2011) 1.03
Molecular determinants of glycine receptor alphabeta subunit sensitivities to Zn2+-mediated inhibition. J Physiol (2005) 1.02
Not all hERG pore domain mutations have a severe phenotype: G584S has an inactivation gating defect with mild phenotype compared to G572S, which has a dominant negative trafficking defect and a severe phenotype. J Cardiovasc Electrophysiol (2009) 1.02
A regulatory domain in the C-terminal extension of the yeast glycerol channel Fps1p. J Biol Chem (2004) 1.02
A combinatorial pattern discovery approach for the prediction of membrane dipping (re-entrant) loops. Bioinformatics (2006) 1.02
Immunohistochemical staining of post-mortem adult human brain sections. Nat Protoc (2006) 1.01
Diversity of glycine receptors in the mouse retina: localization of the alpha3 subunit. J Comp Neurol (2003) 1.01
LRRK2 signaling pathways: the key to unlocking neurodegeneration? Trends Cell Biol (2011) 1.01
Molecular basis of the γ-aminobutyric acid A receptor α3 subunit interaction with the clustering protein gephyrin. J Biol Chem (2011) 1.00